Report cover image

Cochlear Ltd (COH) - Product Pipeline Analysis, 2025 Update

Publisher GlobalData
Published Dec 22, 2025
Length 42 Pages
SKU # GBDT20676714

Description

Summary

Cochlear Ltd (Cochlear) is a medical device company that offers implantable hearing solutions to customers. It develops, manufactures, and markets electronic implantable hearing devices. The company’s products suit people with conductive hearing loss, mixed hearing loss or single-sided deafness. Its major products include cochlear implant systems, bone conduction systems, acoustic implants, bone-anchored prosthetics and wireless accessories. It has manufacturing facilities in Sweden, China, Malaysia, and Australia. The company markets its products through subsidiaries, local offices, distributors and agents. The company has operations in the Americas; Europe, Middle East and Africa; and Asia-Pacific. Cochlear is headquartered in Sydney, New South Wales, Australia.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Cochlear Ltd
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company

Table of Contents

42 Pages
Cochlear Ltd Company Overview
Cochlear Ltd Company Snapshot
Cochlear Ltd Pipeline Products and Ongoing Clinical Trials Overview
Cochlear Ltd – Pipeline Analysis Overview
Business Description
Cochlear Ltd - Key Facts
Cochlear Ltd - Major Products and Services
Cochlear Ltd Pipeline Products by Development Stage
Cochlear Ltd Ongoing Clinical Trials by Trial Status
Cochlear Ltd Pipeline Products Overview
Cochlear Implant With Dexamethasone Eluting Electrode Array
Cochlear Implant With Dexamethasone Eluting Electrode Array Product Overview
Cochlear Implant With Dexamethasone Eluting Electrode Array Clinical Trial
Cochlear Osia OSI300 Implant
Cochlear Osia OSI300 Implant Product Overview
Cochlear Osia OSI300 Implant Clinical Trial
CP1110 Sound Processor
CP1110 Sound Processor Product Overview
Nucleus Profile Plus
Nucleus Profile Plus Product Overview
OSIA 2 System
Product Status
TI1132 Implant
TI1132 Implant Product Overview
TI1132 Implant Clinical Trial
UmboMic
UmboMic Product Overview
Cochlear Ltd - Key Competitors
Cochlear Ltd - Key Employees
Cochlear Ltd - Key Employee Biographies
Cochlear Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Cochlear Ltd, Recent Developments
Jul 08, 2025: Cochlear Receives FDA Approval for the Cochlear Nucleus Nexa System and Nucleus Kanso 3 and Kanso 3 Nexa Sound Processors
Jul 08, 2025: Cochlear Launches World’s First and Only Smart Cochlear Implant System
Jun 20, 2025: Cochlear celebrates 30 Years in China and the launch of the world's first and only smart hearing implant system
Jun 14, 2025: Cochlear Bone Anchored Solutions Receives 510(K) Clearance For Baha SoundBand
Jun 13, 2025: Cochlear Bone Anchored Solutions Receives 510(K) Clearance For Baha 7 Sound Processor
Jun 12, 2025: Cochlear Launches World’s First and Only Smart Cochlear Implant System With Upgradeable Firmware
Apr 03, 2025: Cochlear Awaits Clarification on Application of US Tariff
Jul 02, 2024: Implantable microphone could lead to fully internal cochlear implants
Jul 02, 2024: Implantable Microphone Could Lead to Fully Internal Cochlear Implants
Apr 28, 2024: Cochlear Americas Receives Additional 510(K) Clearance For Cochlear Osia System
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Cochlear Ltd Pipeline Products and Ongoing Clinical Trials Overview
Cochlear Ltd Pipeline Products by Equipment Type
Cochlear Ltd Pipeline Products by Indication
Cochlear Ltd Ongoing Clinical Trials by Trial Status
Cochlear Ltd, Key Facts
Cochlear Ltd, Major Products and Services
Cochlear Ltd Number of Pipeline Products by Development Stage
Cochlear Ltd Pipeline Products Summary by Development Stage
Cochlear Ltd Ongoing Clinical Trials by Trial Status
Cochlear Ltd Ongoing Clinical Trials Summary
Cochlear Implant With Dexamethasone Eluting Electrode Array - Product Status
Cochlear Implant With Dexamethasone Eluting Electrode Array - Product Description
Cochlear Implant With Dexamethasone Eluting Electrode Array - A Pivotal, Prospective, Multi-centre, Randomised Controlled, 6-month Blinded Investigation Followed by a 6-month Open-label Phase Evaluating the Efficacy of a Dexamethasone Eluting Slim Straight Electrode (CI622D) in the Reduction of Impedance as Compared to a Standard Slim Straight Electrode (CI622) in a Newly Implanted Adult Population With Post-linguistic, Bilateral, Moderately Severe to Profound Sensorineural Hearing Loss
Cochlear Osia OSI300 Implant - Product Status
Cochlear Osia OSI300 Implant - Product Description
Cochlear Osia OSI300 Implant - Post-Market Clinical Follow-Up of the Osia System and Evaluation of Benefits of Transitioning From the Baha Connect System to the Osia System in Adult Bone Conduction Implant Recipients With Mixed or Conductive Hearing Loss
CP1110 Sound Processor - Product Status
CP1110 Sound Processor - Product Description
Nucleus Profile Plus - Product Status
Nucleus Profile Plus - Product Description
Product Status
OSIA 2 System - Product Description
TI1132 Implant - Product Status
TI1132 Implant - Product Description
TI1132 Implant - A Pivotal, Pre-market, Prospective, Interventional, Multi-centre Study to Evaluate Clinical Benefit, Performance, and Safety of the TI1132 Implant in an Adult Population With Sensorineural Hearing Loss
UmboMic - Product Status
UmboMic - Product Description
Cochlear Ltd, Key Employees
Cochlear Ltd, Key Employee Biographies
Cochlear Ltd, Other Locations
Cochlear Ltd, Subsidiaries
Glossary
List of Figures
Cochlear Ltd Pipeline Products by Equipment Type
Cochlear Ltd Pipeline Products by Development Stage
Cochlear Ltd Ongoing Clinical Trials by Trial Status

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us